[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial.
Autorzy:
Adams H; Department of Nuclear Medicine, Groene Hart Hospital, Bleulandweg 10, 2803 HH, Gouda, the Netherlands. .; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, the Netherlands. . vandeGardeEMW; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, the Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. Vugts DJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Grutters JC; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, the Netherlands.; Division of Heart & Lung, University Medical Center Utrecht, Utrecht, the Netherlands. Oyen WJG; Department of Biomedicals Sciences and Humanitas Clinical and Research Center, Department of Nuclear Medicine, Humanitas University, Milan, Italy.; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, the Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Keijsers RG; Department of Nuclear Medicine, St. Antonius Hospital, Nieuwegein, the Netherlands.
Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands.
Autorzy:
Mfumbilwa ZA; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. Wilschut JA; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. Simons MJHG; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Maastricht University, Care And Public Health Research Institute (CAPHRI), Maastricht, The Netherlands. Ramaekers B; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Maastricht University, Care And Public Health Research Institute (CAPHRI), Maastricht, The Netherlands. Joore M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Maastricht University, Care And Public Health Research Institute (CAPHRI), Maastricht, The Netherlands. Retèl V; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands. der Welle CMC; Santeon Hospital Group, Santeon, Herculesplein 38, 3584 AA, Utrecht, The Netherlands. Schramel FMNH; Santeon Hospital Group, Santeon, Herculesplein 38, 3584 AA, Utrecht, The Netherlands. vandeGardeEMW; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands. Coupé VMH; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Feb 09; Vol. 13 (1), pp. 2349. Date of Electronic Publication: 2023 Feb 09.
Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC.
Autorzy:
Ismail RK; Dutch Institute for Clinical Auditing, Leiden, the Netherlands. .; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands. .; Medicines Evaluation Board, Utrecht, The Netherlands. . Schramel FMNH; Department of Pulmonary Diseases, St Antonius Hospital, Nieuwegein, The Netherlands. van Dartel M; Medicines Evaluation Board, Utrecht, The Netherlands. Pasmooij AMG; Medicines Evaluation Board, Utrecht, The Netherlands. der Welle CMC; Santeon Hospital Group, Utrecht, The Netherlands. Hilarius DL; Department of Clinical Pharmacy, Rode Kruis Hospital, Beverwijk, The Netherlands. de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands. Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands. vandeGardeEMW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2023 Jan 27; Vol. 23 (1), pp. 26. Date of Electronic Publication: 2023 Jan 27.
Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC.
Autorzy:
Ismail RK; Dutch Institute for Clinical Auditing, Leiden, the Netherlands. .; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands. .; Medicines Evaluation Board, Utrecht, The Netherlands. . Schramel FMNH; Department of Pulmonary Diseases, St Antonius Hospital, Nieuwegein, The Netherlands. van Dartel M; Medicines Evaluation Board, Utrecht, The Netherlands. Pasmooij AMG; Medicines Evaluation Board, Utrecht, The Netherlands. Cramer-van der Welle CM; Santeon Hospital Group, Utrecht, The Netherlands. Hilarius DL; Department of Clinical Pharmacy, Rode Kruis Hospital, Beverwijk, The Netherlands. de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Medicines Evaluation Board, Utrecht, The Netherlands. Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands. vandeGardeEMW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2023 Jan 03; Vol. 23 (1), pp. 1. Date of Electronic Publication: 2023 Jan 03.
Validation of the PreOperative Score to predict Post-Operative Mortality (POSPOM) in Dutch non-cardiac surgery patients.
Autorzy:
Stolze A; Department of Anesthesiology, Amsterdam University Medical Centre, VU University Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. . vandeGardeEMW; Department of Clinical Pharmacy, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands. Posthuma LM; Department of Anesthesiology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Hollmann MW; Department of Anesthesiology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. de Korte-de Boer D; Department of Anesthesiology and Pain Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands. Smit-Fun VM; Department of Anesthesiology and Pain Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands. Buhre WFFA; Department of Anesthesiology and Pain Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands. Boer C; Department of Anesthesiology, Amsterdam University Medical Centre, VU University Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. Noordzij PG; Department of Anesthesiology, Intensive Care and Pain management, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC.
Autorzy:
Verschueren MV; Department of Clinical Pharmacy, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Utrecht/Nieuwegein, The Netherlands. . van der Welle CMC; Santeon Hospital Group, Utrecht, The Netherlands. Tonn M; Department of Clinical Pharmacy, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Utrecht/Nieuwegein, The Netherlands. Schramel FMNH; Department of Pulmonary Diseases, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands. Peters BJM; Department of Clinical Pharmacy, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Utrecht/Nieuwegein, The Netherlands. vandeGardeEMW; Department of Clinical Pharmacy, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Utrecht/Nieuwegein, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Dec 02; Vol. 11 (1), pp. 23331. Date of Electronic Publication: 2021 Dec 02.
Risk factors for nonvisualization of the sentinel lymph node on lymphoscintigraphy in breast cancer patients.
Autorzy:
Chahid Y; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. .; Department of Clinical Pharmacy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. . Qiu X; Department of Clinical Pharmacy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. vandeGardeEMW; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, the Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. Verberne HJ; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. Booij J; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
EJNMMI research [EJNMMI Res] 2021 Jun 09; Vol. 11 (1), pp. 54. Date of Electronic Publication: 2021 Jun 09.
Metabolomic profiling of microbial disease etiology in community-acquired pneumonia.
Autorzy:
den Hartog I; Division of Systems Biomedicine & Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. Zwep LB; Division of Systems Biomedicine & Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.; Mathematical Institute, Leiden University, Leiden, The Netherlands.; Leiden Centre of Data Science, Leiden University, Leiden, The Netherlands. Vestjens SMT; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands. Harms AC; Division of Systems Biomedicine & Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. Voorn GP; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands. de Lange DW; Intensive Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; National Poison Information Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Bos WJW; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.; Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands. Hankemeier T; Division of Systems Biomedicine & Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. vandeGardeEMW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands. van Hasselt JGC; Division of Systems Biomedicine & Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jun 04; Vol. 16 (6), pp. e0252378. Date of Electronic Publication: 2021 Jun 04 (Print Publication: 2021).
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands.
Autorzy:
Cramer-van der Welle CM; Santeon Hospital Group, Santeon, Herculesplein 38, 3584 AA, Utrecht, The Netherlands. c.van.. Verschueren MV; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands. Tonn M; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands. Peters BJM; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands. Schramel FMNH; Department of Pulmonary Diseases, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands. Klungel OH; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Groen HJM; Department of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. vandeGardeEMW; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Nieuwegein, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands.
Autorzy:
Reesink DJ; Urology Department, St. Antonius Hospital, Koekoekslaan 1, 3435CM, Nieuwegein/Utrecht, The Netherlands. . vandeGardeEMW; Clinical Pharmacy Department, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands. Peters BJM; Clinical Pharmacy Department, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands. van der Nat PB; Value Based Healthcare Department, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands. Los M; Oncology Department, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands. Horenblas S; Urology Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands. van Melick HHE; Urology Department, St. Antonius Hospital, Koekoekslaan 1, 3435CM, Nieuwegein/Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Sep 25; Vol. 10 (1), pp. 15822. Date of Electronic Publication: 2020 Sep 25.
Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis.
Autorzy:
Daniels K; Department of Value-Based Healthcare, St. Antonius Hospital, Utrecht/Nieuwegein, Netherlands.; Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Netherlands. van der Nat PB; Department of Value-Based Healthcare, St. Antonius Hospital, Utrecht/Nieuwegein, Netherlands.; Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Netherlands. Frequin STFM; Department of Neurology, St. Antonius Hospital, Utrecht/Nieuwegein, Netherlands. van der Wees PJ; Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Netherlands. Biesma DH; Department of Value-Based Healthcare, St. Antonius Hospital, Utrecht/Nieuwegein, Netherlands.; Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, Netherlands. Hoogervorst ELJ; Department of Neurology, St. Antonius Hospital, Utrecht/Nieuwegein, Netherlands. vandeGardeEMW; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University, Utrecht, Netherlands.
Pokaż więcej
Źródło:
Multiple sclerosis international [Mult Scler Int] 2020 Jun 15; Vol. 2020, pp. 5463451. Date of Electronic Publication: 2020 Jun 15 (Print Publication: 2020).
Intra-operative red blood cell transfusion and mortality after cardiac surgery.
Autorzy:
Vlot EA; Department of Anesthesiology, Intensive Care and Pain Medicine, St Antonius Hospital, Koekoekslaan 1, 3430 EM, Nieuwegein, The Netherlands. . Verwijmeren L; Department of Anesthesiology, Intensive Care and Pain Medicine, St Antonius Hospital, Koekoekslaan 1, 3430 EM, Nieuwegein, The Netherlands. vandeGardeEMW; Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands. Kloppenburg GTL; Department of Cardiac Surgery, St Antonius Hospital, Nieuwegein, The Netherlands. van Dongen EPA; Department of Anesthesiology, Intensive Care and Pain Medicine, St Antonius Hospital, Koekoekslaan 1, 3430 EM, Nieuwegein, The Netherlands. Noordzij PG; Department of Anesthesiology, Intensive Care and Pain Medicine, St Antonius Hospital, Koekoekslaan 1, 3430 EM, Nieuwegein, The Netherlands.
Pokaż więcej
Źródło:
BMC anesthesiology [BMC Anesthesiol] 2019 May 04; Vol. 19 (1), pp. 65. Date of Electronic Publication: 2019 May 04.
Consecutive antibiotic use in the outpatient setting: an extensive, longitudinal descriptive analysis of antibiotic dispensing data in the Netherlands.
Autorzy:
de Jong LAW; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, P.O. Box 9101, 6500 HB, Nijmegen, the Netherlands. . van der Linden PD; Department of Clinical Pharmacy, Tergooi Hospital, van Riebeeckweg 212, 1213 XZ, Hilversum, Netherlands. Roukens MMB; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, P.O. Box 9101, 6500 HB, Nijmegen, the Netherlands. vandeGardeEMW; Department of Pharmaceutical Science, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Universiteitsweg 99, 3584 CA, Utrecht, the Netherlands. van der Velden AW; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (STR 6.103), Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. Natsch S; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, P.O. Box 9101, 6500 HB, Nijmegen, the Netherlands.
Randomized Controlled Trial on the Influence of Intraoperative Remifentanil versus Fentanyl on Acute and Chronic Pain after Cardiac Surgery.
Autorzy:
de Hoogd S; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands. Ahlers SJGM; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands. van Dongen EPA; Department of Anesthesiology and Intensive Care, St. Antonius Hospital, Nieuwegein, The Netherlands. vandeGardeEMW; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands. Daeter EJ; Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands. Dahan A; Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands. Tibboel D; Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands. Knibbe CAJ; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.; Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.; Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Decision support systems for incurable non-small cell lung cancer: a systematic review.
Autorzy:
Révész D; Department of Epidemiology and Biostatistics, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands. . Engelhardt EG; Department of Epidemiology and Biostatistics, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.; Department of Epidemiology and Biostatistics, VU University Medical Center, EMGO Institute for Health and Care Research, De Boelelaan 1089a, 1081, HV, Amsterdam, The Netherlands. Tamminga JJ; Department of Public and Occupational Health, and Palliative Care Expertise Centre, The EMGO Institute for Health and Care Research (EMGO+), VU University Medical Centre, De Boelelaan 1089a, 1081, HV, Amsterdam, The Netherlands. Schramel FMNH; Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.; Department of Lung Diseases and Treatment, St. Antonius Hospital, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands. Onwuteaka-Philipsen BD; Department of Epidemiology and Biostatistics, VU University Medical Center, EMGO Institute for Health and Care Research, De Boelelaan 1089a, 1081, HV, Amsterdam, The Netherlands. vandeGardeEMW; Department of Clinical Pharmacy, St. Antonius Hospital, Koekoekslaan 1, 3435, CM, Nieuwegein, The Netherlands. Steyerberg EW; Department of Public Health, Centre for Medical Decision Making, Erasmus MC, Rotterdam, The Netherlands. Jansma EP; Medical Library, Vrije Universiteit, Amsterdam, The Netherlands.; VU University Medical Center, Medical Information and Library, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. De Vet HCW; Department of Epidemiology and Biostatistics, VU University Medical Center, EMGO Institute for Health and Care Research, De Boelelaan 1089a, 1081, HV, Amsterdam, The Netherlands. Coupé VMH; Department of Epidemiology and Biostatistics, VU University Medical Center, EMGO Institute for Health and Care Research, De Boelelaan 1089a, 1081, HV, Amsterdam, The Netherlands.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
